ABSTRACT. The expression of osteopontin (OPN) in the hearts of rats with experimental autoimmune myocarditis (EAM) was evaluated. Western blot analysis showed that OPN was significantly increased in the hearts with EAM compared with those of complete Freund's adjuvant (CFA) immunized control. Immunohistochemically, OPN was weakly expressed in the cardiomyocytes in the heart with normal and CFA immunized controls. In EAM lesions, OPN was intensely immunostained in some inflammatory cells, mainly ED1 positive macrophages. These findings suggest that OPN is significantly increased in EAM lesions and that OPN mediates the inflammatory process in the course of rat EAM model. KEY WORDS: autoimmune myocarditis, macrophages, osteopontin.
Experimental autoimmune myocarditis (EAM) in rats is an autoimmune inflammatory cardiac disorder that serves as the animal model for human giant cell myocarditis [7] . The EAM lesion is characterized by the infiltration of autoreactive T cells and macrophages in the myocardium, leading to myocardial cell death. Several inflammatory mediators, including cytokines [6] , nitric oxide synthase [9] and osteopontin [4] , have been found to be involved in the pathogenesis of EAM.
Osteopontin (OPN) is an integrin-and calcium-binding phosphoprotein produced by mineralized tissue cells, epithelial cells, and activated immune system cells [1] . OPN is known to have cytokine-like, chemotactic, and pro-adhesive properties, but OPN may require one of its receptors, for example, CD44, for cell adhesion [10] . OPN is abundantly expressed by infiltrating macrophages during wound healing and has been implicated in tissue repair in the heart [8] and in the central nervous system with experimental autoimmune encephalomyelitis [5] . Although the gene level of OPN has been determined in the rat EAM heart model [4] , the protein level and cellular localization of OPN in autoimmune disease of the heart have not been studied.
The aim of the present study was to examine the expression of OPN and of one of its receptors, CD44, in the heart tissues of rats with EAM.
EAM was induced in Lewis rats (Sprague-Dawley, Inc., Indianapolis, IN) as previously described [9] . Male rats aged 7-12 weeks old and weighing 160-200 g were used in the experiments. In brief, five rats were each administered 0.2 ml of human cardiac myosin (2 mg/ml) mixed with an equal volume of complete Freund's adjuvant and supplemented with 5 mg/ml of Mycobacterium tuberculosis H37RA (CFA) (Difco, Detroit, MI), by an injection into the footpad on days 1 and 7. On day 2, each rat received an intraperitoneal injection of 500 ng of Bordetella pertussis toxin (Sigma, St. Louis, MO). The same number of age-and sex-matched male Lewis rats served as untreated controls. The CFA controls were challenged with phosphate-buffered saline in CFA, followed by an intraperitoneal injection of pertussis toxin as previously described [9] . The rats were sacrificed under ether anesthesia on day 16 post-immunization (n=5/each group) when cardiac inflammation was commonly seen in EAM affected rats. The hearts were removed and were either frozen for protein analysis or fixed in 4% paraformaldehyde for routine paraffin embedding. Transverse sections of paraffin-embedded blocks were cut and stained with hematoxylin and eosin.
Western blot analysis was performed as previously described [5] to examine the expression pattern of OPN in the EAM-affected hearts. The following antibodies were used for immunohistochemistry and Western blot analyses: monoclonal anti-OPN antibodies (Akm2A1, sc-21742, IgG1) (Santa Cruz Biotechnology, Santa Cruz, CA), monoclonal anti-rat CD44 (OX49) (Pharmingen, San Diego, CA), and monoclonal anti-beta actin (Sigma). The density of each band obtained by Western blot analysis was measured with a scanning laser densitometer (GS-700, Bio-Rad) using Molecular Analyst software (Bio-Rad). The ratios of OPN in each group were compared using a one-way analysis of variance (ANOVA), followed by a Newman-Keuls post hoc test. In all cases, p<0.05 was considered statistically significant.
To localize OPN and CD44 in the EAM-affected hearts, 5-μm sections of paraffin-embedded heart tissue were deparafinized and then pretreated with citrate buffer (0.01 M, pH 6.0) in the microwave for 1 min. After several washings with phosphate buffer and blocking with normal serum, the sections were incubated with primary antisera, including monoclonal anti-OPN antibodies and anti-rat CD44. To identify macrophages, mouse monoclonal anti-rat macrophage antibodies (ED1, Serotec, London, UK) were applied. The immunoreaction was visualized as an avidin-biotin-per-oxidase complex by using an Elite kit (Vector, Burlingame, CA). Peroxidase was developed with a diaminobenzidine substrate kit (Vector). Before being mounted, the sections were counterstained with hematoxylin. To co-localize OPN and CD44 in the macrophages, a serial section was immunostained with anti-OPN and ED1 or anti-rat CD44. The colocalization of both antigens in the same cell was occasionally detected. Figure 1 shows the histology of heart with CFA-immunized control (Fig. 1A) and with EAM affected rats on day 16 post-immunization (Fig. 1B) . There was necrosis of cardiomyocytes, massive infiltration of inflammatory cells in the myocardium, in which the phenotypes of inflammatory cells were known to be mainly macrophages and T cells in previous papers [4, 7, 9] .
As shown in Fig. 2 (upper photo), two bands of reactivity for OPN in rat hearts were detected at the approximate molecular weights of 60 and 30 kDa. An OPN immunoreaction was constitutively detected in the control hearts with only CFA immunization (Fig. 2, CFA control) . The 60 kDa OPN band was significantly enhanced in the hearts with EAM compared with the CFA immunized control hearts (Fig. 2 , CFA control vs. EAM; density, mean OD/mm 2 value ± S.E.: 1.65 ± 0.05 vs. 3.58 ± 0.31; p<0.05). The 30 kDa OPN band was also significantly enhanced in the EAM tissues (Fig. 2 , CFA control vs. EAM; density, mean OD/ mm 2 value ± S.E.: 4.3 ± 0.45 vs. 6.52 ± 0.14; p<0.05). The expression level of OPN in untreated normal rat heart was quite similar to those of only CFA immunized controls (data not shown). This finding suggests that two major types of OPN were significantly increased in the hearts with EAM.
In untreated normal rats, OPN was weakly immunostained in some cardiomyocytes of heart. In CFA immunized group, the immunostaining pattern of OPN (Fig. 3A) was similar to those of untreated group. In the inflammatory lesions of the EAM hearts (day 16 post-immunization), some inflammatory cells, mainly ED1 positive macrophages (Fig. 3B) , were positive for OPN (Fig. 3C) , suggesting that macrophages are one of the source of OPN in EAM lesions. As well, OPN was also immunostained in cardiomyocytes in EAM lesions. In adjacent sections immunostained with anti-rat CD44 antibodies, a majority of OPN-positive cells were also positive for CD44 (Fig. 3D) . Additionally, some small, round cells, which were identical to T cells, in the epicardium were shown to be positive for OPN by this staining protocol (data not shown), and they had weak immunoreactivity.
This is the first report that OPN is increased with the initiation of autoimmune cardiac inflammation. Based on the results from the Western blot analysis of OPN, we postulated that inflammatory cells in heart tissues with EAM are important sources of OPN. This finding is in agreement with the results of gene expression studies of OPN in EAM [4] , which found that the OPN gene was particularly increased in hearts with EAM. OPN has been identified in macrophages during the repair of myocardial necrosis [8] and in cardiomyocytes associated with ventricular hypertrophy [2] . The present findings agree with the studies on the expression of OPN in macrophages in damaged heart tissue [8] . We infer that macrophages in EAM lesions temporarily express OPN at the early activation stage in inflammation and subsequently secrete OPN molecules into the extracellular matrix at the early inflammatory stage. In the advanced lesions of EAM, some macrophages were shown to be negative for OPN, suggesting that OPN was used out in some macrophages. A similar finding was also noted in spinal cords with experimental autoimmune encephalomyelitis (EAE) in which only a few macrophages expressed OPN at the peak stage of EAE [5] . The presence of OPN in inflammatory EAM lesions suggests that OPN is involved in the facilitation of cell migration into the heart, possibly through the interaction with CD44. An additional role of OPN is the inhibition of matrix metalloproteinase activity in adult rat cardiac fibroblasts [11] in which the up-regulation of MMP-2 and MMP-9 has been shown to be related to the onset of EAM [12] . In the present study, macrophages were found to infiltrate the myocardium and secrete OPN in EAM lesions at the early stage of macrophage activation. Subsequently, OPN may inhibit MMP-2 and MMP-9 in EAM lesions, possibly ameliorating EAM.
Guo et al. [2] found that OPN is a negative feedback regulator of nitric oxide synthesis in murine macrophages, and we found in our previous study that nitric oxide is an important molecule in the pathogenesis of EAM in rats [9] . Given the finding in our previous study that some macrophages in EAM lesions were devoid of immunoreactivity to inducible nitric oxide synthase [9] , we postulate that OPN suppresses the activity of inducible nitric oxide synthase of macrophages in EAM. The precise interaction between OPN and the generation of nitric oxide is unknown.
Based on our results and those of previous studies, we propose that OPN in hearts with EAM might be involved in cell migration at the early stage of EAM inflammation and that the major source of OPN in EAM lesions is macrophages in the rat EAM heart model. 
